O4, Jared Holz of Mizuho joined ‘Power Lunch’ on CNBC to talk about how to play biotech moving into 2026. Holz noted that ...
Over the past few years, Axsome Therapeutics has made slow and steady clinical and regulatory progress. The company's lineup ...
Zacks.com on MSN
3 Biotech Stocks With Major 2026 Catalysts
Biotech's 2025 rebound sets the stage for Denali Therapeutics and two peers, with key FDA decisions and pipeline catalysts ...
Legend Biotech Corp (NASDAQ:LEGN) is one of the best biotech stocks to buy according to Wall Street analysts. On December 8, RBC Capital reiterated an Outperform rating on Legend Biotech Corp ...
AbbVie is in advanced talks to buy cancer-drug developer Revolution Medicines, the Wall Street Journal reported on Wednesday, ...
The biotech sector has put up a strong recovery in 2025. The Nasdaq Biotechnology Index has risen 33.1% so far this year. The index bottomed out in April 2025 on potential imposition of steep tariffs, ...
A successful Phase 3 trial and a public offeringof stock boosted prospects for this company to receive approval for an ...
This stock is a great choice for cautious and aggressive investors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback